Pharsight

UCB PHARMA patents facing oppositions

Top patents of UCB PHARMA facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2645997B1 10 Aug, 2022 Once daily formulation of lacosamide Dec, 2031 1
EP2345668B1 22 Sep, 2021 Sclerostin epitopes Apr, 2026 1
EP3670528B1 08 Sep, 2021 Sclerostin binding agents NA 1
EP2992891B1 05 Aug, 2020 Pharmaceutical composition comprising brivaracetam and lacosamide with synergistic anticonvulsant effect Jun, 2027 1
EP2869844B2 18 Dec, 2019 Treatment for bone diseases NA 1
EP2037965B1 30 Aug, 2017 Pharmaceutical composition with synergistic anticonvulsant effect Jun, 2027 1